Astex Pharmaceuticals is a world leader in innovative drug discovery and development. The company has successfully applied its proprietary fragment-based drug discovery platform to generate multiple new drug candidates that are progressing in clinical development. Successful collaborations have led to three launched oncology drugs (Kisqali partnered with Novartis, Balversa partnered with Janssen and Truqap partnered with Astra Zeneca). Astex continues to grow and focuses on Oncology and Neurological Disorders.
Astex has pioneered the use of electron cryo-microscopy (cryo-EM) in fragment- and structure-based drug discovery (FBDD and SBDD). We have established a state-of-the-art, in-house cryo-EM facility, including an extensive and dedicated computing infrastructure. We have also developed custom data collection and processing workflows to facilitate the rapid generation and interpretation of cryo-EM structures for SBDD and FBDD. Astex is a member of the Cambridge Cryo-EM Consortium and has multiple collaborations with cryo-EM centres of excellence, including the MRC-LMB, the University of Cambridge, the University of Oxford, the CSIC Biocomputing Unit (Madrid) and Monash University (Australia).
MNCJobs.co.uk will not be responsible for any payment made to a third-party. All Terms of Use are applicable.